| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 25 |
| 1 | FLUOROURACIL CREAM, 0.5% | 25 |
| 2 | OXALIPLATIN | 17 |
| 3 | BEVACIZUMAB | 11 |
| 4 | PACLITAXEL | 9 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 9 |
| 6 | CARBOPLATIN | 8 |
| 7 | CYCLOPHOSPHAMIDE | 6 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PASIREOTIDE | 2 | 0.0009 |
| 1 | EPIRUBICIN HYDROCHLORIDE | 5 | 0.0008 |
| 2 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 3 | FLUOROURACIL CREAM, 0.5% | 25 | 0.0003 |
| 4 | FLUOROURACIL | 25 | 0.0003 |
| 5 | OXALIPLATIN | 17 | 0.0002 |
| 6 | APREPITANT | 1 | 0.0001 |
| 7 | LANREOTIDE ACETATE | 1 | 0.0001 |
| 8 | RIFAMPICIN | 1 | 0.0001 |
| 9 | AMLODIPINE BESYLATE AND VALSARTAN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 27 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 26 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Methylxanthine [EPC] | 1 | 0.0000 |